OGM for Cell Bioprocessing QC
Genomic integrity of cell therapy and producer cell lines
CommercialMarketed Application
Key Facts
Indication
Genomic integrity of cell therapy and producer cell lines
Phase
Commercial
Status
Marketed Application
Company
About Bionano Genomics
Bionano Genomics is on a mission to transform the way the world sees the genome through its optical genome mapping technology, which detects structural variants missed by traditional cytogenetics and sequencing. The company has commercialized its OGM systems and software, with over 500 publications citing its use in research and clinical applications. Bionano's strategic focus is on driving adoption in clinical cytogenomics and research labs to improve the diagnosis and understanding of cancers and genetic diseases.
View full company profile